Skip to main content
Premium Trial:

Request an Annual Quote

Columbia Inks $30M Genomics Research Alliance with Biogen Idec

NEW YORK (GenomeWeb) – Biogen Idec and Columbia University Medical Center today announced they have signed a $30 million agreement to establish a research facility to study the genetics of disease and find new drug targets.

The partners will build a sequencing and analysis facility and create a postdoctoral program at Columbia to support collaborative genetics studies. The agreement, they said, brings together genomics research conducted at Columbia with Biogen's expertise in discovering new medicines.

The deal will allow Biogen to look at the genomes of patients with unique diseases and patients showing unusual treatment responses. The drug-development firm said that as part of the collaboration, it will explore the connections among genes, pathways, and disease processes with the goal of discovering targets for new therapeutics.

"This collaboration marries the exceptional drug development expertise of Biogen with cutting-edge genomics expertise at Columbia University Medical Center," David Goldstein, director of Columbia's Institute for Genomic Medicine, said in a statement. "It will not only focus on target identification and validation at the early stages of drug development, but also facilitate genetically informed evaluation of treatments."

The new facility will have broad genetic research capabilities and the capacity to quickly complete whole-genome sequencing projects. It will allow for DNA sequencing in a range of diseases, focusing on those with significant unmet clinical needs, such as amyotrophic lateral sclerosis and idiopathic pulmonary fibrosis, Biogen said.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.